Captrust Financial Advisors Pulse Biosciences, Inc. Transaction History

Captrust Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$1.48 - $4.28 $2,616 - $7,567	1,768 Added 27.02%	8,311 $13,000
Q1 2022 May 16, 2022	SELL	$4.21 - $14.79 $88 - $310	-21 Reduced 0.32%	6,543 $32,000
Q1 2021 May 17, 2021	SELL	$22.43 - $44.27 $10,743 - $21,205	-479 Reduced 6.8%	6,564 $155,000
Q4 2020 Feb 16, 2021	BUY	$11.66 - $24.5 $2,040 - $4,287	175 Added 2.55%	7,043 $168,000
Q2 2020 Aug 14, 2020	BUY	$6.23 - $13.09 $42,787 - $89,902	6,868 New	6,868 $70,000

Q4 2019 Feb 14, 2020	SELL	$12.58 - $15.97 $18,870 - $23,955	-1,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.69 - $19.44 $17,535 - $29,160	1,500 New	1,500 $26,000

4.72M

239K

94.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $415M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.